Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
377.9 USD | -0.10% | +0.80% | -0.16% |
17/06 | Wedbush Adjusts Price Target on argenx to $519 From $521, Maintains Outperform Rating | MT |
13/06 | Pliant Therapeutics, Inc. Appoints Steve Krognes to Its Board of Directors | CI |